Log In
Print this Print this

Apocept (APG101)

  Manage Alerts
Collapse Summary General Information
Company Apogenix GmbH
DescriptionSoluble fusion protein combining the extracellular domain of CD95 and the Fc portion of IgG
Molecular Target CD95 ligand
Mechanism of Action 
Therapeutic ModalityBiologic: Fusion protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today